Skip to content
Study details
Enrolling now

Salvage Radiation Therapy for Metastatic Cancer

M.D. Anderson Cancer Center
NCT IDNCT02710253ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

230

Study length

about 10 years

Ages

18+

Locations

5 sites in TX

What this study is about

Researchers are testing if radiation therapy can help control metastatic cancer after immunotherapy. The trial will evaluate different types of radiation and how well it works in patients with advanced cancer that has progressed despite treatment with immunotherapy.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Laboratory Biomarker Analysis
  • 2.Receive External Beam Radiation Therapy
  • 3.Receive Stereotactic Body Radiation Therapy

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Incidence of adverse events, Objective response (partial response or complete response)

Secondary: Overall survival, Progression free survival

Procedures

radiation